{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0001816",
      "entity_text" : "cytokine production",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:3488",
      "entity_text" : "Glibenclamide",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Glibenclamide reduces pro inflammatory cytokine production by neutrophils of diabetes patients in response to bacterial infection.",
  "reading_complete" : "2020-07-28T08:26:15Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T08:25:07Z",
  "trigger" : "reduces",
  "evidence" : [ "Glibenclamide reduces pro-inflammatory cytokine production" ],
  "pmc_id" : "3842541",
  "score" : 0
}